Norepinephrine topical - ProCertus BioPharm

Drug Profile

Norepinephrine topical - ProCertus BioPharm

Alternative Names: DermX; Noradrenaline; OralX; PRO-200; ProDermaCel

Latest Information Update: 21 Sep 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator ProCertus BioPharm; University of Wisconsin Comprehensive Cancer Center
  • Class Antihypotensives; Catecholamines; Ethanolamines
  • Mechanism of Action Adrenergic receptor agonist antagonists; Adrenergic receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • No development reported Alopecia; Radiodermatitis; Stomatitis

Most Recent Events

  • 17 Apr 2016 Biomarkers information updated
  • 21 Sep 2015 No recent reports on development identified - Phase-I for Alopecia (Prevention) in USA (Topical)
  • 21 Sep 2015 No recent reports on development identified - Phase-I/II for Radiodermatitis (Prevention) in USA (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top